Skip to main content

R.grid

R.grid provides an AI-driven automation platform that integrates trial management processes from pre-trial to trial close, significantly reducing administrative errors and delays. Its products, Inclusive and TrialEngine, streamline patient recruitment and automate complex workflows, cutting trial timelines by months and enhancing overall trial success rates.

Traction 10/10
London, United Kingdom · HQ
Founded 2019113K+ followers
  • Artificial Intelligence
  • Enterprise Software
  • Healthcare Technology
  • Software Only
Updated 1 month ago

Funding

Raised to date

$8MRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.

$6.5M across 1 disclosed round

+4

$6.5M · Seed

Announced Nov 2024 · from article date

Disclosed cumulative: $6.5M

Reported total $8M

Incomplete round history. $1.5M of the $8M reported total isn’t matched to a known round.

Founders

Founder details are not available yet.

Product

Problem

Clinical trials often face significant administrative burdens and manual processes, leading to delays and errors in patient recruitment, data management, and reporting. Traditional clinical trial management systems (CTMS) involve complex workflows that can take months or even years to complete, creating bottlenecks and increasing costs.

Solution

R.grid offers an AI-powered automation platform designed to streamline clinical trial management from pre-trial to trial close. The platform's two core products, Inclusive and TrialEngine, work together to automate patient recruitment, engagement, and complex administrative workflows. By connecting every trial stage in one place and leveraging AI to automate manual processes, R.grid aims to reduce trial timelines, minimize administrative errors, and enhance overall trial success rates. Inclusive focuses on patient sourcing and engagement, while TrialEngine handles administration, data, and reporting workflows during and after the trial.

Target Audience

The primary target audience includes clinical trial managers, research institutions, and pharmaceutical companies seeking to accelerate trial timelines, reduce administrative burdens, and improve patient recruitment and engagement.

Features

  • Inclusive: Smart patient, community engagement, sourcing, and management platform for early trial preparation.
  • Inclusive: Access to a large patient network with over 300 million patients across more than 90,000 communities.
  • Inclusive: Smart automations for quick and easy communication with diverse stakeholders and participants.
  • TrialEngine: Clinical trial automation system (CTAS) for administration, data, and reporting workflows.
  • TrialEngine: Custom AI algorithms and process automation for tasks like protocol development and study document extraction.
  • End-to-end platform connecting every trial stage in one place.
This profile is AI-generated and may contain inaccuracies.